Eli Lilly, Novo Nordisk ile Bir Yarışta Ama Hisse Senedi Açık Kazandı

Zepbound maker and drug giant Eli Lilly's (LLY) stock is in the buy zone of a flat base after hitting a new high. The IBD Sector Leaders name is in a race with Novo Nordisk (NVO) in the fast-growing weight-loss medication industry. Lilly makes injectable obesity drug Zepbound and Type 2 diabetes treatment Mounjaro. It launched its weight-loss pill Foundayo in…